Abstract
Canagliflozin (Invokana, JNJ-28431754) is an orally bioavailable and selective SGLT2 (subtype 2 sodium-glucose transport protein) inhibitor approved f......
小提示:本篇文献需要登录阅读全文,点击跳转登录